ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.508,67
1,09%
S&P 500
5.127,79
1,26%
US Dollar vs BRL
5,0724
0,00%
Bitcoin
64.111,76
0,34%
Brent Oil
82,765
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Amgen Inc (AMGN)

  7. Amgen Inc (AMGN) Notícias

AMGN

Amgen (AMGN)

Amgen Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AMGN
DataHoraFonteTítuloCódigoCompanhia
03/05/202410:12IH Market NewsAmgen, Bock Up; Cloudflare, Expedia WeakNASDAQ:AMGNAmgen Inc
02/05/202417:01PR Newswire (US)AMGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTSNASDAQ:AMGNAmgen Inc
01/05/202408:00PR Newswire (US)AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024NASDAQ:AMGNAmgen Inc
29/04/202417:00PR Newswire (US)AMGEN ANNOUNCES WEBCAST OF 2024 FIRST QUARTER FINANCIAL RESULTSNASDAQ:AMGNAmgen Inc
26/04/202410:00PR Newswire (US)AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCYNASDAQ:AMGNAmgen Inc
16/04/202418:26PR Newswire (US)AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024NASDAQ:AMGNAmgen Inc
09/03/202414:20PR Newswire (US)AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024NASDAQ:AMGNAmgen Inc
08/03/202419:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
06/03/202418:00PR Newswire (US)AMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDENDNASDAQ:AMGNAmgen Inc
29/02/202418:00PR Newswire (US)AMGEN TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTH CARE CONFERENCENASDAQ:AMGNAmgen Inc
26/02/202411:00PR Newswire (US)AMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN CENTRAL OHIONASDAQ:AMGNAmgen Inc
19/02/202418:00PR Newswire (US)AMGEN TO HOST CONFERENCE CALL ON RARE DISEASENASDAQ:AMGNAmgen Inc
14/02/202418:23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:AMGNAmgen Inc
09/02/202418:00PR Newswire (US)AMGEN TO PRESENT AT THE 34TH ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCENASDAQ:AMGNAmgen Inc
07/02/202407:49IH Market NewsMoody’s Downgrades NYCB to Junk Status, Ford Declares Special Dividend, and Other Market UpdatesNASDAQ:AMGNAmgen Inc
06/02/202419:05IH Market NewsU.S. Stocks Finish Choppy Trading Day Modestly HigherNASDAQ:AMGNAmgen Inc
06/02/202418:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMGNAmgen Inc
06/02/202418:01PR Newswire (US)AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTSNASDAQ:AMGNAmgen Inc
06/02/202408:27IH Market NewsUS Index Futures Mixed, Oil Prices Edge HigherNASDAQ:AMGNAmgen Inc
02/02/202418:25IH Market NewsU.S. Stocks Extend Thursday’s Rally On Upbeat Meta, Amazon ResultsNASDAQ:AMGNAmgen Inc
01/02/202418:00PR Newswire (US)AMGEN ANNOUNCES WEBCAST OF 2023 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTSNASDAQ:AMGNAmgen Inc
29/01/202407:00PR Newswire (Canada)deCODE genetics: A sequence variant that increases risk of pregnancy lossNASDAQ:AMGNAmgen Inc
17/01/202408:33IH Market NewsWall Street Highlights: Tesla Cuts Prices in Germany, Interactive Brokers Increases Revenue by 17%, and MoreNASDAQ:AMGNAmgen Inc
10/01/202412:12Dow Jones NewsXeris Biopharma Shares Climb 12% on Amgen License AgreementNASDAQ:AMGNAmgen Inc
10/01/202410:53Dow Jones NewsXeris Biopharma Reaches License Agreement With Amgen On Thyroid Eye Disease TreatmentNASDAQ:AMGNAmgen Inc
10/01/202410:45InvestorsHub NewsWireGLP-1: Beyond Diabetes, a Blockbuster Horizon BeckonsNASDAQ:AMGNAmgen Inc
03/01/202418:00PR Newswire (US)AMGEN TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCENASDAQ:AMGNAmgen Inc
02/01/202413:42Dow Jones NewsAmgen On Pace for Record High Close -- Data TalkNASDAQ:AMGNAmgen Inc
26/12/202311:00PR Newswire (US)AMGEN PROVIDES REGULATORY UPDATE ON STATUS OF LUMAKRAS® (SOTORASIB)NASDAQ:AMGNAmgen Inc
19/12/202322:38Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AMGN

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
GOLL4
GOL PN
BOV
BHIA3
Grupo Casas Bahia ON
BOV
AZEV4
AZEVEDO PN
BOV
AZUL4
AZUL PN
BOV
PRIO3
PETRORIO ON
BOV
HETA4
HERCULES PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados